The global intradermal injection market size is expected to surpass an impressive valuation of USD 3,878 Million in 2022 and is projected to exhibit a compound annual growth rate (CAGR) of 10.8% from ...

The global Injectable Drug Delivery Market, valued at US$633.7 billion in 2024, is forecasted to grow at a robust CAGR of 8.4 ...

The global Injectable Drug Delivery Market, valued at US$633.7 billion in 2024, is forecasted to grow at a robust CAGR of 8.4%, reaching US$690.23 ...

Some types of PD-1 and PD-L1 inhibitors are available as subcutaneous injections that a cancer care professional injects into fat under the skin. These subcutaneous medications include ...

In the main PRAETORIAN report, the investigators had shown that the subcutaneous ICD matched the transvenous ICD on efficacy ...

The subcutaneous formulation of daratumumab makes treatment a faster and more tolerable process for patients with multiple ...

CINCINNATI, April 25, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable ... underutilization of promising large-volume subcutaneous oncology therapies and misconceptions hindering ...

Using the latest data and perspectives, an international expert panel releases updated recommendations for optimal insulin ...

Hooven, Chairman and CEO of Enable Injections. "Our enFuse platform is uniquely positioned to address challenges in developing large-volume subcutaneous oncology drugs. This wearable delivery system ...